Grants awarded to improve investigation and detection of eye diseases

Article

Fight for Sight has awarded six £15,000 grants to support ophthalmic research in the UK.

Fight for Sight has awarded six £15,000 grants to support ophthalmic research in the UK. These monies will help study in the development of the following areas: earlier detection of glaucoma, improving success of corneal transplants, understanding the causes of inherited retinal disease and informing healthcare provision.

Successful applicants of the grant include doctors from the Glaucoma Research Unit of the Norfolk and Norwich University Hospital, the School of Ophthalmology and Vision Science at the University of Cardiff, the Vision and Eye Research Unit of Anglia Ruskin University in Cambridge, Moorfields Eye Hospital and the UCL Institute of Ophthalmology.

For more information visit www.fightforsight.org.uk/research

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.